Ads
related to: merck- Cell Therapy Production
Cell Therapy Manufacturing Services
From Clinical To Commercial
- AAV Reference Standards
Essential AAV Reference Standards
Full & Empty Capsids of 6 Serotypes
- GMP Retrovirus Services
cGMP-compliant & fully scalable
Viral vector manufacturing
- GMP QC Services
Viral Vector & Plasmid Assays
Quality, Sterility & Potency
- Cell Therapy Production
Search results
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comp
Guru Focus· 43 minutes agoMerck & Co Inc (MRK, Financial) recently experienced a daily loss of 2.46%, contributing to a three-month decline of 0.74%. With an Earnings Per Share (EPS) of 0.9, the question ...
Roche’s Sabry retires; Duchenne drug fails confirmatory test
BioPharma Dive via Yahoo Finance· 5 hours agoThe veteran executive will be replaced by Boris Zaïtra. Elsewhere, Nippon Shinyaku shared negative...
Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Simply Wall St. via Yahoo Finance· 5 hours agoMerck (NYSE:MRK) has had a rough month with its share price down 1.3%. To decide if this trend could...
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 4 hours agoMerck & Co (NYSE:MRK) announced on Tuesday that its phase 3 KEYNOTE-522 trial evaluating Keytuda...
Dow Jones Falls As Nvidia Rallies To Record Highs; GameStop Soars On Stock Sale
Investor's Business Daily· 2 hours agoStock Market Today: Best Stocks To Watch Monday.com, Netflix and Crocs — plus Dow Jones components ...
Merck On Track for Largest Percent Decrease Since October 2023 — Data Talk
Morningstar· 1 hour agoMerck & Co., Inc. (MRK) is currently at $126.30, down $3.19 or 2.46% --Would be lowest close since April 19, 2024, when it closed at $125.78 --On pace for largest percent decrease since Oct. 27, 2023, when it fell 2.59% --Currently
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 2 hours agoUS-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 3 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Are Investors Undervaluing Merck KGaA (ETR:MRK) By 29%?
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights The projected fair value for Merck KGaA is €236 based on 2 Stage Free Cash Flow to...
Dow Jones Futures Fall, But Nvidia Leads Techs Higher; 7 Stocks Near Buy Points
Investor's Business Daily· 5 hours agoThe Dow Jones and Russell 2000 had solid losses as consumer, housing, commodity and software names...